Syneos Health Launches Medical Affairs Digital Amplifier
March 27 2023 - 7:30AM
Syneos Health® (Nasdaq: SYNH), a leading fully integrated
biopharmaceutical solutions organization, today announced the
launch of Medical Affairs Digital Amplifier, a program designed to
drive smarter and more effective scientific exchange. This
integrated program seeks to ensure customers, and the clinicians
they serve, have access to the latest education to optimize patient
outcomes.
The development of this unique digital asset underscores Syneos
Health’s continued focus on Medical Affairs, an increasingly
critical component of successful clinical development. Fueled by
the Company’s advanced digital engagement capabilities and
data-enabled technology solutions, the program includes two
components that can work together or independently, helping to
develop flexible and tailored solutions for customers’ needs:
- Medical Science Liaison (MSL) Digital
Amplifier: Automates the delivery of key educational
messages and clinical information in a relevant and digestible
format. Amplifier parallels face-to-face education and email
communication between HCPs and MSLs, creating coordinated and
synchronized MSL and HCP experiences.
- Engagement activity is tracked through the MSL Digital
Amplifier proprietary analytics platform enabling customers to view
who is engaging with what messages and when, helping inform next
best actions and future communications, with the goal of increasing
meaningful interactions.
- Conference Digital Amplifier: Magnifies key
stakeholder reach for account management meetings during and after
live industry events.
- During a conference, attendees are sent display banners
customized to align with a customer’s specific meeting strategy
(e.g., encourage booth traffic or generate MSL appointments). After
the conference, highly relevant stakeholders can be further engaged
with for an additional four weeks to help initiate additional
interactions (e.g., visits to the Medical Affairs educational
website and MSL meetings).
- This program further allows customers to engage with key
stakeholders virtually before and after an event.
“Medical innovation is constantly advancing, while data is
exponentially increasing in volume and complexity. Our Medical
Affairs team serves as the hub and conduit to accelerate knowledge
consumption, enabling our customers to have more meaningful
engagement with the healthcare communities they serve,” said Suma
Ramadas, PhD, Executive Vice President, Medical Affairs, Syneos
Health. “Medical Affairs Digital Amplifier elevates our deep domain
expertise by enabling greater reach and impact for our customers’
medical education strategies. We’re excited to bring this
technology-based program forward, further advancing our customers’
performance to change patients’ lives.”
The launch of Medical Affairs Digital Amplifier continues the
Company’s investment in differentiating technology and data
solutions that aim to amplify biopharmaceutical customers’ success
across the clinical to commercial continuum.
About Syneos HealthSyneos Health® (Nasdaq:SYNH)
is a leading fully integrated biopharmaceutical solutions
organization built to accelerate customer success. We translate
unique clinical, medical affairs and commercial insights into
outcomes to address modern market realities.
We bring together a talented team of professionals, who work
across more than 110 countries, with a deep understanding of
patient and physician behaviors and market dynamics. Together
we share insights, use the latest technologies and apply advanced
business practices to speed our customers’ delivery of important
therapies to patients.
Syneos Health supports a diverse, equitable and inclusive
culture that cares for colleagues, customers, patients, communities
and the environment.
To learn more about how we are Shortening the distance
from lab to life®, visit syneoshealth.com
or subscribe to our podcast.
Investor Relations Contact: Ronnie
SpeightSenior Vice President, Investor Relations+1 919 745
2745Investor.Relations@syneoshealth.com |
|
Press/Media Contact:Gary GatyasExecutive Director,
External Communications+1 908 763
3428 gary.gatyas@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024